Maelstrom Research Staging | COVAXHIV_HIV_COV_PLWH_4_weeks_post_dose

COVAXHIV_HIV_COV_PLWH_4_weeks_post_dose_1

Networks -

Variables -

Associated study COVAXHIV Contingency Table

Population

COVAXHIV - HIV-COV PLWH

The population is composed of individuals 16 years of age and older, who are HIV-positive and who are receiving a COVID-19 vaccination or have received 1 or 2 doses of a COVID-19 vaccine.

Selection Criteria

Minimum age

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Participants are included if they are HIV-positive.
Participants are excluded if they present signs or symptoms of active COVID-19 infection.

Other Criteria

Participants are excluded if they received 3 COVID-19 doses prior to enrolment.

Supplementary Information about selection criteria

The following group is prioritized for the study enrolment and contributes to at least to 20% of the HIV-COV PLWH recruitment (per category): * Older age (55 years and over), * Immune non-responders (CD4 T cell count less than 350 cells/mm3, CD4/CD8 less than 0.75 with undetectable viral load for at least 6 months), * With 2 or more comorbidities, and/or * HIV-positive “stable” (CD4 T cell counts equal to or more than 350 cells/mm3 with undetectable HIV viral load for at least 6 months, and a maximum of 1 comorbidity).

Recruitment

Sources of recruitment

General population
Specific population

General Population

Volunteer enrolment

Specific Population

Clinic patients

Supplementary Information

Participants are informed about the study through a recruitment flyer during routine physician visits to their HIV clinic and via established recruitment strategies through our community partners and the CIHR Canadian HIV Trials Network via webpages, email, and social media platforms. 100 HIV positive participants will be recruited from each of the 4 sites in Montreal, Ottawa, Toronto and Vancouver.

Number of Participants

Number of Participants: 400
Number of Participants with Biological Samples: 400
Supplementary Information about selection criteria

More info

Data Collection Event

COVAXHIV - HIV-COV PLWH - 4 weeks post dose 1

Information on COVID-19 history and exposure, health behaviours, adverse events post-vaccination, concomitant medications and medication changes, symptoms of respiratory illness, and general health was or will be collected. Blood samples were or will be collected.

More info

Collected Dataset / COVAXHIV_HIV_COV_PLWH_4_weeks_post_dose_1

COVAXHIV_HIV_COV_PLWH_4_weeks_post_dose_1

Population

COVAXHIV - HIV-COV PLWH

Data Collection Event

COVAXHIV - HIV-COV PLWH - 4 weeks post dose 1

Files

Variables Classifications